Cadila Healthcare To Sell Animal Healthcare Business To Become A Focused Entity: Dolat Capital
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Dolat Capital Report
Cadila Healthcare Ltd. has entered into an agreement to sell its animal healthcare business to Zenex Animal Health India through a slump sale for a consideration of Rs 29 billion.
Zenex is an special purpose vehicle managed by Rare Enterprises, Multiples Alternate AMC and Canada Pension Plan Investment Board (CPPIB).
The transaction is expected to be earnings per share neutral in the near term and is expected to be completed in the next three months, subject to shareholders’ approval.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.